Patents by Inventor Cameron Black

Cameron Black has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10883677
    Abstract: A lighting system is disclosed that includes elongated LED light fixture with one or more master circuit boards configured to power light-emitting diodes. The elongated LED light fixtures include modular light boards, with arrays of light-emitting diodes, that interchangeably couple to the matched connectors on the master circuit board. The system further includes elongated LED light fixtures with telescoping end features, fenestrated diffuser optics at ends of the elongated LED fight fixtures, and/or pivoting corner features that join sections of the elongated LED light fixtures.
    Type: Grant
    Filed: October 1, 2019
    Date of Patent: January 5, 2021
    Assignee: FINELITE INC
    Inventors: Jeffry Mellor, Brian McIntyre, Stephen Zanoni, Aaron Matthew Smith, Marlon Ebido, Cameron Black, Walter Blue Clark, Johannes Dale Toale
  • Publication number: 20200041079
    Abstract: A lighting system is disclosed that includes elongated LED light fixture with one or more master circuit boards configured to power light-emitting diodes. The elongated LED light fixtures include modular light boards, with arrays of light-emitting diodes, that interchangeably couple to the matched connectors on the master circuit board. The system further includes elongated LED light fixtures with telescoping end features, fenestrated diffuser optics at ends of the elongated LED fight fixtures, and/or pivoting corner features that join sections of the elongated LED light fixtures.
    Type: Application
    Filed: October 1, 2019
    Publication date: February 6, 2020
    Applicant: FINELITE INC.
    Inventors: Jeffry Mellor, Brian McIntyre, Stephen Zanoni, Aaron Matthew Smith, Marlon Ebido, Cameron Black, Walter Blue Clark, Johannes Dale Toale
  • Patent number: 10495272
    Abstract: A lighting system is disclosed that includes elongated LED light fixture with one or more master circuit boards configured to power light emitting diodes. The elongated LED light fixtures include modular light boards with arrays of light emitting diodes that interchangeably couple to the matched connectors on the master circuit board. The system further includes elongated LED light fixtures with telescoping end features, fenestrated diffuser optics at ends of the elongated LED fight fixtures and/or pivoting corner features that join sections of the elongated LED light fixtures.
    Type: Grant
    Filed: August 20, 2018
    Date of Patent: December 3, 2019
    Assignee: Finelite INC.
    Inventors: Jeffry Mellor, Brian McIntyre, Stephen Zanoni, Aaron Matthew Smith, Marlon Ebido, Cameron Black, Walter Blue Clark, Johannes Dale Toale
  • Publication number: 20190024856
    Abstract: A lighting system is disclosed that includes elongated LED light fixture with one or more master circuit boards configured to power light emitting diodes. The elongated LED light fixtures include modular light boards with arrays of light emitting diodes that interchangeably couple to the matched connectors on the master circuit board. The system further includes elongated LED light fixtures with telescoping end features, fenestrated diffuser optics at ends of the elongated LED fight fixtures and/or pivoting corner features that join sections of the elongated LED light fixtures.
    Type: Application
    Filed: August 20, 2018
    Publication date: January 24, 2019
    Applicant: FINELITE INC.
    Inventors: Jeffry Mellor, Brian Mclntyre, Stephen Zanoni, Aaron Matthew Smith, Marlon Ebido, Cameron Black, Walter Blue Clark, Johannes Dale Toale
  • Patent number: 10150787
    Abstract: The invention encompasses the novel class of compounds represented by the Formula (I) below, which are inhibitors of the TC-PTP enzyme. The invention also encompasses pharmaceutical compositions which include the compounds shown above and methods of treating or preventing TC-PTP mediated diseases, including cancer, via their use in the activation of antigen-presenting cells, like dendritic cells, for applications in the immunotherapeutic treatment of diseases.
    Type: Grant
    Filed: May 22, 2018
    Date of Patent: December 11, 2018
    Inventors: Michel L. Tremblay, Claudia Penafuerte, Matthew Feldhammer, George Zogopoulos, Cameron Black, Brian Kennedy
  • Publication number: 20180265531
    Abstract: The invention encompasses the novel class of compounds represented by the Formula (I) below, which are inhibitors of the TC-PTP enzyme. The invention also encompasses pharmaceutical compositions which include the compounds shown above and methods of treating or preventing TC-PTP mediated diseases, including cancer, via their use in the activation of antigen-presenting cells, like dendritic cells, for applications in the immunotherapeutic treatment of diseases.
    Type: Application
    Filed: May 22, 2018
    Publication date: September 20, 2018
    Inventors: Michel L. TREMBLAY, Claudia PENAFUERTE, Matthew FELDHAMMER, George ZOGOPOULOS, Cameron BLACK, Brian KENNEDY
  • Patent number: 10060583
    Abstract: A lighting system is disclosed that includes elongated LED light fixture with one or more master circuit boards configured to power light emitting diodes. The elongated LED light fixtures include modular light boards with arrays of light emitting diodes that interchangeably couple to the matched connectors on the master circuit board. The system further includes elongated LED light fixtures with telescoping end features, fenestrated diffuser optics at ends of the elongated LED fight fixtures and/or pivoting corner features that join sections of the elongated LED light fixtures.
    Type: Grant
    Filed: July 24, 2017
    Date of Patent: August 28, 2018
    Inventors: Jeffry Mellor, Brian McIntyre, Stephen Zanoni, Aaron Matthew Smith, Marlon Ebido, Cameron Black, Walter Blue Clark, Johannes Dale Toale
  • Patent number: 10005804
    Abstract: The invention encompasses the novel class of compounds represented by the Formula (I) below, which are inhibitors of the TC-PTP enzyme. The invention also encompasses pharmaceutical compositions which include the compounds shown above and methods of treating or preventing TC-PTP mediated diseases, including cancer, via their use in the activation of antigen-presenting cells, like dendritic cells, for applications in the immunotherapeutic treatment of diseases.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: June 26, 2018
    Inventors: Michel L. Tremblay, Claudia Penafuerte, Matthew Feldhammer, George Zogopoulos, Cameron Black, Brian Kennedy
  • Publication number: 20180072763
    Abstract: The invention encompasses the novel class of compounds represented by the Formula (I) below, which are inhibitors of the TC-PTP enzyme. The invention also encompasses pharmaceutical compositions which include the compounds shown above and methods of treating or preventing TC-PTP mediated diseases, including cancer, via their use in the activation of antigen-presenting cells, like dendritic cells, for applications in the immunotherapeutic treatment of diseases.
    Type: Application
    Filed: September 20, 2017
    Publication date: March 15, 2018
    Inventors: Michel L. TREMBLAY, Claudia PENAFUERTE, Matthew FELDHAMMER, George ZOGOPOULOS, Cameron BLACK, Brian KENNEDY
  • Publication number: 20170350564
    Abstract: A lighting system is disclosed that includes elongated LED light fixture with one or more master circuit boards configured to power light emitting diodes. The elongated LED light fixtures include modular light boards with arrays of light emitting diodes that interchangeably couple to the matched connectors on the master circuit board. The system further includes elongated LED light fixtures with telescoping end features, fenestrated diffuser optics at ends of the elongated LED fight fixtures and/or pivoting corner features that join sections of the elongated LED light fixtures.
    Type: Application
    Filed: July 24, 2017
    Publication date: December 7, 2017
    Applicant: FINELITE INC.
    Inventors: Jeffry Mellor, Brian Mclntyre, Stephen Zanoni, Aaron Matthew Smith, Marlon Ebido, Cameron Black, Walter Blue Clark, Johannes Dale Toale
  • Patent number: 9828399
    Abstract: The invention encompasses the novel class of compounds represented by the Formula (I) below, which are inhibitors of the TC-PTP enzyme. The invention also encompasses pharmaceutical compositions which include the compounds shown above and methods of treating or preventing TC-PTP mediated diseases, including cancer, via their use in the activation of antigen-presenting cells, like dendritic cells, for applications in the immunotherapeutic treatment of diseases.
    Type: Grant
    Filed: February 27, 2015
    Date of Patent: November 28, 2017
    Assignee: The Royal Institution For The Advancement Of Learning/McGill University
    Inventors: Michel L. Tremblay, Claudia Penafuerte, Matthew Feldhammer, George Zogopoulos, Cameron Black, Brian Kennedy
  • Publication number: 20170015690
    Abstract: The invention encompasses the novel class of compounds represented by the Formula (I) below, which are inhibitors of the TC-PTP enzyme. The invention also encompasses pharmaceutical compositions which include the compounds shown above and methods of treating or preventing TC-PTP mediated diseases, including cancer, via their use in the activation of antigen-presenting cells, like dendritic cells, for applications in the immunotherapeutic treatment of diseases.
    Type: Application
    Filed: February 27, 2015
    Publication date: January 19, 2017
    Applicant: THE ROYAL INSTITUTE FOR THE ADVANCEMENT OF LEARNING / MCGILL UNIVERSITY
    Inventors: Michel L. TREMBLAY, Claudia PENAFUERTE, Matthew FELDHAMMER, George ZOGOPOULOS, Cameron BLACK, Brian KENNEDY
  • Publication number: 20150250759
    Abstract: The present invention relates to the a method of inhibiting bone resorption in a mammal in need thereof with an oral pharmaceutical composition comprising a cathepsin K inhibitor, or a pharmaceutically acceptable salt thereof, or a mixture thereof, according to a continuous schedule having a dosage interval of once weekly, biweekly, twice monthly or once monthly.
    Type: Application
    Filed: May 21, 2015
    Publication date: September 10, 2015
    Applicant: MERCK SHARP & DOHME CORP.
    Inventors: Anastasia Daifotis, Selwyn Aubrey Stoch, Basil Avery Ince, Cameron Black
  • Publication number: 20140256743
    Abstract: This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.
    Type: Application
    Filed: May 20, 2014
    Publication date: September 11, 2014
    Applicants: Merck Frosst Canada Ltd., Axys Pharmaceuticals, Inc.
    Inventors: Christopher I. Bayly, Cameron Black, Serge Leger, Chun Sing Li, Dan McKay, Christophe Mellon, Jacques Yves Gauthier, Vouy-Linh Truong, Cheuk Lau, Michel Therien, Michael J. Green, Bernard L. Hirschbein, James William Janc, James T. Palmer, Chitra I. Baskaran
  • Patent number: 8772336
    Abstract: This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.
    Type: Grant
    Filed: October 11, 2012
    Date of Patent: July 8, 2014
    Assignees: Merck Frosst Canada Ltd., Axys Pharmaceuticals, Inc.
    Inventors: Christopher I. Bayly, Cameron Black, Serge Leger, Chun Sing Li, Dan McKay, Christophe Mellon, Jacques Yves Gauthier, Vouy-Linh Truong, Cheuk Lau, Michel Therien, Michael J. Green, Bernard L. Hirschbein, James William Janc, James T. Palmer, Chitra I. Baskaran
  • Publication number: 20140186471
    Abstract: The present invention relates to the a method of inhibiting bone resorption in a mammal in need thereof with an oral pharmaceutical composition comprising a cathepsin K inhibitor, or a pharmaceutically acceptable salt thereof, or a mixture thereof, according to a continuous schedule having a dosage interval of once weekly, biweekly, twice monthly or once monthly.
    Type: Application
    Filed: March 5, 2014
    Publication date: July 3, 2014
    Inventors: Anastasia Daifotis, Selwyn Aubrey Stoch, Basil Avery Ince, Cameron Black
  • Patent number: 8722734
    Abstract: The present invention relates to the a method of inhibiting bone resorption in a mammal in need thereof with an oral pharmaceutical composition comprising a cathepsin K inhibitor, or a pharmaceutically acceptable salt thereof, or a mixture thereof, according to a continuous schedule having a dosage interval of once weekly, biweekly, twice monthly or once monthly.
    Type: Grant
    Filed: February 24, 2006
    Date of Patent: May 13, 2014
    Assignees: Merck Sharp & Dohme Corp., Merck Canada Inc.
    Inventors: Anastasia Daifotis, Selwyn Aubrey Stoch, Basil Avery Ince, Cameron Black
  • Patent number: 8318748
    Abstract: This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.
    Type: Grant
    Filed: May 25, 2011
    Date of Patent: November 27, 2012
    Assignees: Merck, Sharp & Dohme Corp., Axys Pharmaceuticals, Inc.
    Inventors: Christopher I. Bayly, Cameron Black, Serge Leger, Chun Sing Li, Dan McKay, Christophe Mellon, Jacques Yves Gauthier, Vouy-Linh Truong, Cheuk Lau, Michel Therien, Michael J. Green, Bernard L. Hirschbein, James William Janc, James T. Palmer, Chitra Baskaran
  • Publication number: 20120101053
    Abstract: The present invention relates to compounds capable of inhibiting and/or decreasing the activity of one or more cathepsins, thereby treating and/or preventing various disease states associated with one or more cysteine proteases including, but not limited to, cathepsins and papain-like cysteine proteases. Disease states treated and/or prevented by the compounds of the invention include, but are not limited to, mammalian parasitic diseases in which the parasite utilizes a critical cysteine protease from the papain family. Examples of parasitic diseases to be treated or prevented by the compounds of the invention include, but are not limited to, toxoplasmosis, malaria, African trypanosomiasis, Chagas disease, leishmaniasis, coccidiosis, giardiosis, cryptosporidiosis or schistosomiasis.
    Type: Application
    Filed: June 16, 2010
    Publication date: April 26, 2012
    Inventors: Cameron Black, Christian Beaulieu
  • Publication number: 20120011751
    Abstract: An audio greeting card is typically manufactured with pre-recorded songs that play when the greeting card is opened. The purchaser of an audio greeting card is limited to the songs already selected for such cards. A customizable audio greeting card is provided, for which the user can select the audio that is played. The audio greeting card has an audio receiving and playback device, with a connector for receiving audio information. User-selected audio information is sent to the greeting card and identifiable information is generated pertaining to the sent audio information. The identifiable information may be printed onto a label for affixing to the greeting card or may be printed directly onto the greeting card. The identifiable information is utilized when completing the sale of the customized greeting card, thereby indicating the finalized customization of the user-selected audio played on the purchased audio greeting card.
    Type: Application
    Filed: July 14, 2010
    Publication date: January 19, 2012
    Inventors: Scott A. Schimke, Jennifer Cameron Black, Mark J. Reichert